“Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer”
Randomized trial comparing 2 external beam radiotherapy fractionation schemes in patients with localized high risk prostate cancer. Primary endpoint is acute toxicity.
Radiation - Conventionally Fractionated versus Hypofractionated Boost
Randomized Trial of Concomitant Hypofractionated IMRT Boost Versus Conventional Fractionated IMRT Boost for Localized High Risk Prostate Cancer